Ménière’s disease is a chronic inner ear disorder that causes sudden episodes of spinning vertigo, fluctuating hearing loss, ringing in the ear, and a feeling of pressure or fullness on the affected side. Episodes strike unpredictably, lasting anywhere from 20 minutes to 12 hours, and over time the disease can cause permanent hearing damage. It affects roughly one ear at first, though about a third of people eventually develop symptoms in both ears.
What Happens Inside the Inner Ear
The inner ear contains a fluid called endolymph that bathes the delicate structures responsible for both hearing and balance. In Ménière’s disease, too much of this fluid accumulates, a condition called endolymphatic hydrops. The excess fluid swells the membranes that separate different compartments of the inner ear, physically distorting the structures that detect sound and motion.
The damage follows a specific pattern. The tiny hair-like sensors (stereocilia) on the outer hearing cells are the first to deteriorate, starting in the region of the inner ear that processes low-pitched sounds. This is why early hearing loss in Ménière’s disease typically shows up in the low and mid frequencies on a hearing test, while higher-pitched hearing stays relatively intact at first. Over time, inner hair cells are lost too, and the damage spreads to affect a broader range of frequencies. Changes in the chemical composition of the endolymph, particularly its calcium concentration, likely contribute to these functional losses beyond the mechanical stretching alone.
The Four Core Symptoms
Ménière’s disease is defined by a cluster of four symptoms that come and go together, though not always with equal intensity:
- Vertigo: Intense spinning that can be severe enough to cause nausea, vomiting, and an inability to stand. These episodes appear without warning.
- Hearing loss: A muffled quality or noticeable drop in hearing, especially for lower-pitched sounds. Early on, hearing often returns to normal between episodes, but repeated attacks cause cumulative damage.
- Tinnitus: A ringing, buzzing, or roaring sound in the affected ear that typically worsens during or just before an episode.
- Aural fullness: A sensation of pressure deep in the ear, similar to what you might feel during altitude changes on a flight.
The pattern tends to shift over the years. Early in the disease, vertigo episodes are the most disruptive feature. As time passes, vertigo attacks may become less frequent or even stop, but hearing loss and tinnitus often become more persistent and harder to manage.
How Ménière’s Disease Is Diagnosed
There is no single blood test or scan that confirms Ménière’s disease. Diagnosis rests on your symptom history and a hearing test. The current clinical criteria require at least two spontaneous vertigo episodes lasting 20 minutes to 12 hours, along with documented low- to mid-frequency hearing loss on an audiogram taken before, during, or after a vertigo episode. You also need fluctuating hearing symptoms (tinnitus, hearing loss, or fullness) in the affected ear, and your doctor must rule out other balance disorders that could explain the picture.
Because many conditions can mimic parts of this symptom cluster, including vestibular migraines and benign positional vertigo, getting to a definite diagnosis sometimes takes time and repeat testing.
First-Line Treatment: Diet and Medication
Treatment for Ménière’s disease is stepped, starting with the least invasive options and escalating only when symptoms remain poorly controlled.
Reducing sodium intake is one of the most widely recommended lifestyle changes. The goal is to keep daily sodium under 2,000 mg, which is noticeably lower than what most people consume. The logic is straightforward: less sodium means your body retains less fluid overall, which may reduce the excess inner ear fluid driving symptoms. Some research suggests that cutting sodium below 3,000 mg per day is enough to trigger hormonal changes that help the inner ear reabsorb fluid more effectively. In practice, this means reading labels carefully, cooking at home more often, and limiting processed and restaurant foods.
Betahistine is considered a first-choice medication in many countries for reducing the frequency and severity of vertigo episodes between attacks. Expert consensus supports a daily dose in the 32 to 48 mg range, taken for a minimum of three months if you’ve had one to three attacks in the previous six months, and for six months to a year if attacks are more frequent. Side effects occur in fewer than 10% of patients. Betahistine is not approved in the United States, but it is widely prescribed in Europe and other regions. It does not appear to prevent hearing loss.
Diuretics (water pills) are also commonly prescribed to reduce fluid retention in the inner ear. Despite their widespread use, a Cochrane review found no high-quality clinical trials demonstrating that diuretics improve vertigo, hearing loss, tinnitus, or aural fullness in Ménière’s disease. Some lower-quality studies do report improvement in vertigo, so many clinicians still offer them, but the evidence base is thin.
Injections Through the Eardrum
When dietary changes and daily medication fail to control vertigo, the next step is often an injection delivered directly through the eardrum into the middle ear space, where the medication can reach the inner ear.
Two approaches are commonly used, and they work very differently. Steroid injections reduce inflammation in the inner ear without damaging its structures. They carry a lower risk profile but also lower vertigo control rates: guidelines from the American Academy of Otolaryngology report complete vertigo control in 31% to 90% of patients, a wide range that reflects inconsistent results across studies.
Gentamicin injections take a more aggressive approach. Gentamicin is an antibiotic that is selectively toxic to the balance cells in the inner ear, essentially dialing down the faulty signals causing vertigo. It achieves complete vertigo control in 70% to 87% of patients. A meta-analysis found that gentamicin was significantly more effective than steroids at the six-month mark, though by 12 months the difference between the two narrowed and was no longer statistically significant. The trade-off is that gentamicin carries a real risk of worsening hearing loss, since its toxic effects are not perfectly selective.
Surgical Options for Severe Cases
Surgery is reserved for people whose vertigo remains disabling despite less invasive treatments.
Endolymphatic sac decompression is the most conservative surgical option. The procedure opens space around the endolymphatic sac, a structure behind the inner ear believed to regulate fluid drainage. Across multiple studies, 68% to 90% of patients achieved either complete control or substantial improvement in vertigo. The surgery preserves hearing in most cases, making it an attractive option for people who still have usable hearing in the affected ear.
For the most refractory cases, more destructive procedures exist. These involve either cutting the balance nerve or surgically removing the balance structures entirely. These procedures are highly effective at eliminating vertigo but sacrifice any remaining balance function on that side, and in some cases hearing as well. The brain can compensate for the loss of one balance organ over time, but the adjustment period takes weeks to months.
Long-Term Outlook and Bilateral Risk
Ménière’s disease is unpredictable. Some people experience a handful of episodes and then the disease goes quiet for years. Others face frequent, debilitating attacks that reshape their daily lives.
One of the most important things to understand is the risk of the disease spreading to the other ear. About 2.4% of people have bilateral involvement at the time of diagnosis. Within the first year, that figure rises to nearly 14%. By four years, roughly 28% have hearing loss in both ears, and after ten years, about 35% are affected bilaterally. In about half of those who develop bilateral disease, the second ear becomes involved within two years of the first.
This progression has practical implications. Hearing preservation matters more when there is a meaningful chance the other ear will eventually be affected. It also means that treatments which sacrifice hearing or balance function in one ear, while effective for vertigo, carry higher stakes if the disease later appears on the opposite side.
Living With Ménière’s Disease
Between the medical treatments, the day-to-day management of Ménière’s disease comes down to minimizing triggers and staying safe during episodes. Many people learn to recognize warning signs, often a sudden increase in ear fullness or a change in tinnitus, that signal an attack is building. When vertigo strikes, lying still in a dark room with your eyes closed is the most effective way to ride it out.
Driving is a significant concern. A vertigo episode behind the wheel is dangerous, and clinicians routinely advise patients with active, unpredictable episodes to avoid driving until their symptoms are better controlled. The National Highway Traffic Safety Administration considers conditions that temporarily limit driving fitness to be the responsibility of the treating clinician rather than the DMV, meaning the guidance you receive from your doctor carries real weight even if there is no formal license restriction in most states.
Stress, poor sleep, caffeine, and alcohol are commonly reported triggers, though the evidence is largely anecdotal and varies from person to person. Keeping a symptom diary can help you identify your own patterns. Many people also benefit from vestibular rehabilitation, a type of physical therapy that trains the brain to compensate for unreliable balance signals from the affected ear, particularly during quieter periods between attacks.